As part of effort to reduce the burden of Hypertension and Cardiovascular disease on the continent, a Biopharmaceutical company, Astrazeneca’ has revealed its plans to reach out to 10 million Hypertensive patients in Sub-Sahara Africa, in a programme tagged “Healthy Heart Africa” which will take the form of education and awareness, training and guidelines along with access and affordability.

No Comments

Leave a Comment